Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Weber

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
British Journal of Haematology|March 13, 2026
Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapyAshleigh P Scott, Ada Lo, Ying Xia, et al.
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
Leukemia & Lymphoma|October 13, 2017
'Real-world' Australian experience of pomalidomide for relapsed and refractory myelomaAshleigh Scott, Nicholas Weber, Campbell Tiley, et al.
Neurobiology of Disease|July 14, 2006
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosisErika L F Holzbaur, David S Howland, Nicholas Weber, et al.
Blood Advances|January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry J Iland, John Reynolds, Alan V Boddy, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
British Journal of Haematology|March 13, 2026
Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapyAshleigh P Scott, Ada Lo, Ying Xia, et al.
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
Leukemia & Lymphoma|October 13, 2017
'Real-world' Australian experience of pomalidomide for relapsed and refractory myelomaAshleigh Scott, Nicholas Weber, Campbell Tiley, et al.
Neurobiology of Disease|July 14, 2006
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosisErika L F Holzbaur, David S Howland, Nicholas Weber, et al.
Blood Advances|January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry J Iland, John Reynolds, Alan V Boddy, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Pageof 4